U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07907731) titled 'Effect of LMWH on Neonatal Outcomes in Isolated Oligohydramnios' on Oct. 24.
Brief Summary: The pregnant women who meet the study requirements will be included in the study. They will be randomly assigned to receive either the usual treatment or the usual treatment along with an additional medicine.
The usual treatment will include fluids given through a vein, rest while lying on the left side, and a low-dose aspirin tablet (75 mg once daily) from the 22nd to the 34th week of pregnancy. Women will also receive 1,000 ml of 5% dextrose fluid daily through a vein, from the time low amniotic fluid is diagnosed until the 36th week of pr...